1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Stand Up To Cancer–PNOC DMG Discoveries Challenge Grant 2026 is sponsored by Stand Up To Cancer. Supports highly innovative translational research for diffuse midline glioma (DMG), including DIPG, with strong potential to translate discoveries into clinical studies within 18-24 months to improve survival and quality of life for children, adolescents, and young adults.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Stand Up To Cancer–PNOC DMG Discoveries Challenge Grant 2026 - Oncology News, Insights, Stories by OncoDaily Stand Up To Cancer–PNOC DMG Discoveries Challenge Grant 2026 The Stand Up To Cancer–Pediatric Neuro-Oncology Consortium (PNOC) and PNOC Foundation Diffuse Midline Glioma (DMG) Discoveries Challenge provides up to $1,000,000 for up to two years to support highly innovative translational research aimed at achieving a step-change improvement in treatment for diffuse midline glioma (DMG), including diffuse intrinsic pontine glioma (DIPG).
The program is specifically focused on research with strong potential to move rapidly toward patients. Proposed projects should seek to translate promising discoveries into a clinical research study within 18–24 months, with the ultimate goal of improving long-term survival and quality of life for children, adolescents, and young adults diagnosed with DMG.
Applications are submitted by research teams proposing translational DMG research. Projects must focus on diffuse midline glioma, including DIPG. Candidate therapeutic targets and/or interventions should already have been identified.
Projects should be sufficiently mature to support translation toward a clinical research study within approximately 18–24 months. Teams proposing research at an earlier stage of clinical development should clearly explain the pathway toward further development, clinical testing, and eventual implementation.
Applicants should review the full RFA in ProposalCentral before applying, as the publicly accessible announcement does not provide enough information to confirm individual PI or institutional eligibility. Maximum funding: Up to $1,000,000 per project Maximum project period: Up to 2 years A current University of Illinois Cancer Center summary of the RFA states that the program expects to award up to two grants.
The same summary lists an indirect cost limit of 10%. Application deadline: September 30, 2026 Project duration: Up to 2 years Intended clinical translation: Within 18–24 months of project start. Official program information: Visit the PNOC Foundation DMG Discoveries Challenge announcement for the official program overview, funding amount, duration, translational objective, and deadline.
Application portal: Applications are submitted through ProposalCentral ; search for “Stand Up To Cancer” under Grant Opportunities and select the DMG Discoveries Challenge. Detailed RFA and eligibility: Applicants should use the complete RFA available through ProposalCentral to confirm PI eligibility, institutional requirements, permitted costs, team structure, application documents, and the exact submission time.
Program contact: Questions about the opportunity may be directed to the PNOC Foundation using the contact information provided on the official DMG Discoveries Challenge page.
Adolescent and young adult cancer diffuse intrinsic pontine glioma Pediatric Neuro-Oncology Consortium Global fight against cancer MD Anderson Cancer Center Dana-Farber Cancer Institute American Society of Clinical Oncology European Cancer Organisation National Cancer Institute Memorial Sloan Kettering Cancer Center European School of Oncology The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors
According to the current listing, eligibility includes: Research teams proposing translational DMG research; applicants must review full RFA in ProposalCentral for PI and institutional eligibility details. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1,000,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Stand Up To Cancer–PNOC DMG Discoveries Challenge Grant 2026 are due September 30, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Stand Up To Cancer–PNOC DMG Discoveries Challenge Grant 2026 is funded by Stand Up To Cancer. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Stand Up To Cancer – Pediatric Neuro-Oncology Consortium (PNOC) and the PNOC Foundation Diffuse Midline Glioma (DMG) Discoveries Challenge is sponsored by Stand Up To Cancer. This grant program supports highly innovative translational research that provides a step-change improvement in therapy for Diffuse Midline Glioma (DMG), including diffuse intrinsic pontine glioma (DIPG).
Stand Up To Cancer – Pediatric Neuro-Oncology Consortium (PNOC) and the PNOC Foundation Diffuse Midline Glioma (DMG) Discoveries Challenge Grant Program is sponsored by Stand Up To Cancer. Supports highly innovative translational research that provides a step-change improvement in therapy for Diffuse Midline Glioma (DMG), including diffuse intrinsic pontine glioma (DIPG).
Stand Up To Cancer Grants and Awards is sponsored by Stand Up To Cancer. Stand Up To Cancer funds cancer research projects that address critical problems in patient care and deliver near-term patient benefits. They are committed to advancing health equity by supporting research and clinical trials to develop successful strategies, measurable outcomes, and robust outreach to historically underrepresented racial and ethnic minority populations.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article